Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Chronic Pain × nabiximols × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 9 Neoplasms 7 Marijuana Abuse 4 Cancer Pain 4 Glioblastoma 2 Squamous Cell Carcinoma of Head and Neck 1 Signs and Symptoms 1 Recurrence 1 Parasomnias 1 Pancreatic Neoplasms 1 Nausea 1 Mouth Neoplasms 1 Marijuana Use 1 Chronic Pain 1 Cachexia 1 Breast Neoplasms 1 Brain Neoplasms 1 Anxiety Disorders 1 Anorexia 1 Advanced Malignant Solid Tumor 1 Advanced Cancer 1 1- Cancer Patients During Chemotherapy Treatment 1

Interventions

Morphine 7 Ketamine 5 Fentanyl 4 Sodium Chloride 3 Saline Solution 3 Lidocaine 3 Educational Status 3 Dexmedetomidine 3 Cognitive Behavioral Therapy 3 Anesthetics, Local 3 Surveys and Questionnaires 2 Pregabalin 2 Mindfulness-Based Stress Reduction 2 Hypnosis 2 Bupivacaine 2 Acetaminophen 2 tianeptine 1 siltuximab 1 onabotulinum toxin A 1 nabiximols 1 morphine, naltrexone combination 1 erenumab 1 Yoga 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 Tramadol 1 Telemedicine 1 Tea 1 Tapentadol 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03522467 2019-09-25

COPE

Aurora Cannabis Inc

Phase 2 Unknown

Marijuana Abuse, Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡